Chronic kidney disease (CKD) is a common disease affecting up to 16% of the global population1. Given that patients with CKD are at an increased risk of multiple comorbidities, they commonly need a multitude of medications to prevent further progres...

Early Insight to the Dyslipidaemia Pandemic Dyslipidaemia is defined as lipid imbalance affecting the low high-density lipoprotein cholesterol (HDL-C), elevated triglyceride (TG), high low-density lipoprotein cholesterol (LDL-C) and elevated total c...

The Burden of Chronic Kidney Disease Chronic kidney disease (CKD) is one of the most prominent causes of death and suffering in the 21 st century. The number of patients affected by CKD has substantially increased with an estimate of 843.6 million i...

Chronic kidney disease (CKD) is an increasing public health concern with an estimated global prevalence of 10.6% for stages 3-5 and 13.4% for stages 1-5. In 2016, there were 275.9 million cases of CKD with around 1.2 million deaths and 35 million ye...

“Adequate” to “High-quality Goal-directed” In healthcare settings, the delivery of PD primarily focuses on small solute removal and ultrafiltration as highlighted by the International Society for Peritoneal Dialysis (ISPD) gu...

Kidney Health Education for All - A Snapshot on Current Scenario and Action Strategies The Clinical Importance of Health Literacy CKD patients have to make day-to-day decisions about how to self-manage their conditions, including their diet and work...

Dietary Management of Metabolic Acidosis in Chronic Kidney Disease Metabolic acidosis is an acid-base disorder common in patients with chronic kidney disease (CKD) when the glomerular filtration rate (GFR) falls below 30-40 mL/min/1.73 m 2 1,2 . It ...